약학대학 전임교수 목록

교수진/연구실
교수진
전임교수

교수정보의 상세 화면-2019
이름 전상민 학력 박사 전공 약학전공(과)
정보	연구실 : 약학관207호 연구실번호 : 이메일 : jeonsm@snu.ac.kr 연구관심분야 : 진화독성학 기반 암대사 연구 및 항암전략 개발
학력	졸업연도/학교/학위 2011.05 University of Illinois at Chicago 박사 졸업연도/학교/학위 2001.02 서울대학교 석사 졸업연도/학교/학위 1999.02 서울대학교 학사
경력	2012.1~2013,7, Postdoctoral fellow, Research Oncology, Genentech, CA 2001.3~2005.9, Research Scientist, Samsung Biomedical Research Institute, Korea
연구분야	Lab of Integrative Cancer Signaling and Metabolism Network The international cancer genome project has provided comprehensive repertoire of novel oncogenic mutations at the genomic, epigenomic and transcriptomic levels in many tumor types. In the post-cancer genomics era, cancer research is now focused on defining the functional roles of these novel oncogenes and tumor suppressor genes and exploiting them for targeted cancer therapy. However, given that these oncogenic mutations are numerous and even heterogeneous in many tumors, targeting each individual gene should not be an ideal or promising therapeutic strategy. Thus, understanding the most critical convergent downstream of these diverse oncogenic signaling should be indispensable to warrant successful cancer therapy. Recently, a growing body of evidence has convincingly shown that diverse oncogenic signaling pathways converge on the regulation of cell metabolism to support energetic demand for deregulated cancer cell growth, proliferation and survival. In this aspect, cancer metabolism research has become emerging hallmark of cancer and one of the hottest fields in cancer research. In this view, our lab is interested in studying complex network between oncogenic mutations, signaling and metabolic pathways. We now focus on resolving fundamental and important questions to understand this network by employing bioinformatics, proteomics and metabolomics with in vitro & in vivo genetics tools. 1)Which metabolites/metabolic pathways and oncogenic signaling are regulated by diverse genetic & epigenetic mutations in each tumor type? 2)How these mutations regulate signal transduction and metabolic pathways? 3)How these altered metabolism or metabolic pathways contribute to cancer genesis or maintenance. 4)Validate identified metabolites or metabolic pathways as potential therapeutic targets as well as diagnostic markers for cancer. Finally, our long-term goal is to establish diet-metabolism-cancer connection, which will lead us to develop promising strategies for chemoprevention as well as cancer therapy.
논문 및 연구활동	연구활동(주요논문) [논문] Catherine S. Blaha, Gopalakrishnan Ramakrishnan, Veronique Nogueira, Alexander R. Terry, Alexandre F. Aissa, Hyunsoo Rho, Krushna C. Patra, Maxim V. Frolov, Prashanth Bhaskar, R. Brooks Robey, Soeun Kang, 전상민, Nissim Hay, A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis , NATURE COMMUNICATIONS , pp.1 -20 (Feb, 2022) [논문] 전상민, Anju Singh, 최은지, Amy Rappaport, Buvana Ravishankar, Edward Gabrielson, Florian Gnad, George Acquaah-Mensah, Georgia Hatzivassiliou, Kuladeep Sudini, Leisa Johnson, Mark McCleland, Naina Gour, Namrata Patil, Oded Foreman, Samit Chatterjee, Stephane Lajoie, Wayne Mitzner, Anneleen Daemen, Dorothee Nickles, Shyam Biswal, NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes , CLINICAL CANCER RESEARCH (Feb, 2021) [논문] 정병진, 최은지, 이선형, 신은애, 유환식, 고현정, 김수열, 장수환, 전상민, A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer , ONCOGENE , pp.1 -11 (May, 2017) [논문] 전상민, Regulation and Function of AMPK in Physiology and Diseases , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -13 (Jul, 2016) [논문] 전상민, Naveedip Chandel, Nissim Hay, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , NATURE , Vol.485 , pp.661 -665 (May, 2012) 국제학술논문지 [논문] Catherine S. Blaha, Gopalakrishnan Ramakrishnan, Veronique Nogueira, Alexander R. Terry, Alexandre F. Aissa, Hyunsoo Rho, Krushna C. Patra, Maxim V. Frolov, Prashanth Bhaskar, R. Brooks Robey, Soeun Kang, 전상민, Nissim Hay, A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis , NATURE COMMUNICATIONS , pp.1 -20 (Feb, 2022) [논문] 전상민, Anju Singh, 최은지, Amy Rappaport, Buvana Ravishankar, Edward Gabrielson, Florian Gnad, George Acquaah-Mensah, Georgia Hatzivassiliou, Kuladeep Sudini, Leisa Johnson, Mark McCleland, Naina Gour, Namrata Patil, Oded Foreman, Samit Chatterjee, Stephane Lajoie, Wayne Mitzner, Anneleen Daemen, Dorothee Nickles, Shyam Biswal, NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes , CLINICAL CANCER RESEARCH (Feb, 2021) [논문] 전상민, 최여진, 신수영, Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials , NUTRIENTS , pp.1 -19 (Jul, 2020) [논문] 신수영, 박영준, 전상민, 정현주, 윤휘열, 채정우, Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections , RISK MANAGEMENT AND HEALTHCARE POLICY , pp.685 -695 (Jun, 2020) [논문] Tin Tin Manh Nguyen, 안용진, 전상민, Christine Chung, 고윤주, 이준호, 이하니, 차진욱, 박성혁, Real-Time In-Organism NMR Metabolomics Reveals Different Roles of AMP-Activated Protein Kinase Catalytic Subunits , ANALYTICAL CHEMISTRY , pp.7382 -7387 (May, 2020) [논문] 최은지, 전상민, NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective , ARCHIVES OF PHARMACAL RESEARCH , pp.321 -336 (Mar, 2020) [논문] Peter Brown, 전상민, Adrian Meule, Aik-Choon Tan, Andy W. K. Yeung, Arun Richard Chandrasekaran, Carl S. Goodyear, Carlos O. Sorzano, Cong-Cong Yin, Darius Widera, Douglas P. Gladue, Gabriel M. F. Almeida, Junpeng Zhang, Ken Honjo, Luca G. Campana, Marco Cascella, Martin S. Staege, Michael S. Engel, Mohamed A. El-Esawi, Nicholas A. Kurniawan, Oliver Blanck, Olivier Pourret, Swapna V. Daulatabad, Thilo Muth, Thomas Liehr, Tomislav Cernava, Willy A. Flegel, Zhongheng Zhang, Zuzanna Bukowy-Bieryllo, Yaoqi Zhou, Large expert-curated database for benchmarking document similarity detection in biomedical literature search , DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION , pp.1 -66 (Oct, 2019) [논문] 전상민, 주청, 전희숙, 문창규, Diol-ginsenosides from Korean Red Ginseng delay the development of type 1 diabetes in diabetes-prone biobreeding rats , JOURNAL OF GINSENG RESEARCH , pp.1 -8 (Jun, 2019) [논문] 함인혜, 배청아, 손상용, 오혜정, 전상민, 진혜진, 최경숙, 한상욱, Rolf A. Brekken, 이다근, 허훈, Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer , MOLECULAR CANCER , Vol.18 , No.1 , pp.68 -68 (Mar, 2019) [논문] 노유진, 전상민, 신수영, Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy , INTERNATIONAL JOURNAL OF CANCER , pp.1 -32 (Sep, 2018) [논문] 전상민, Nissim Hay, Expanding the concepts of cancer metabolism , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -3 (Apr, 2018) [논문] 신은애, 전상민, Exploring vitamin D metabolism and function in cancer , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -14 (Apr, 2018) [논문] 김신애, 전상민, Shyam K Sharan, 공경엽, 김지선, 김희정, 손병호, 유현주, 이은지, 이종원, 이희진, 정재윤, 채선영, 장수환, microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer , ONCOGENE , Vol.37 , No.22 , pp.2982 -2991 (Mar, 2018) [논문] Jae-Hyoung Song, Seong-Ryeol Kim, 신수영, 전상민, 최은지, Dong-eun Kim, Geun-Shik Lee, Huijeong Ahn, Jae-Hee Ahn, Pyeung-Hyeun Kim, Seung Goo Kang, Sung-il Yoon, Sungchan Cho, Younggil Cha, 장선영, Hyun-Jeong Ko, Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation , ANTIVIRAL RESEARCH , Vol.151 , pp.87 -96 (Mar, 2018) [논문] Dannielle DeWaal, 전상민, Alexander R. Terry, Christopher P. Long, Grace Guzman, Jennifer Au, Krushna C. Patra, Veronique Nogueira, Maciek R. Antoniewicz, Nissim Hay, Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin , NATURE COMMUNICATIONS , Vol.9 , pp.1 -14 (Jan, 2018) [논문] 신수영, 유환식, 정병진, 박영준, 전상민, Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities , BIOMOLECULES & THERAPEUTICS , pp.57 -68 (Dec, 2017) [논문] 정병진, 최은지, 이선형, 신은애, 유환식, 고현정, 김수열, 장수환, 전상민, A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer , ONCOGENE , pp.1 -11 (May, 2017) [논문] 허은영, 홍은혜, 장선영, 권보은, 김진웅, 박예정, 송재형, 이재영, 진영원, 전상민, 고현정, Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells , ONCOTARGET , pp.1 -11 (Apr, 2017) [논문] 김나영, 임화영, 전상민, He N, Mills G, 김소민, 김우영, 김주현, 송미, 이철중, 이혜숙, 정유나, 조용연, 최진성, 윤석준, Cardiac glycosides display selective efficacy for STK11 mutant lung cancer , SCIENTIFIC REPORTS , pp.1 -11 (Jul, 2016) [논문] 전상민, Regulation and Function of AMPK in Physiology and Diseases , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -13 (Jul, 2016) [논문] 권보은, 송재형, 송혁환, 장선영, 전상민, 강주은, 김동은, 김연정, 심애리, 이기종, 조성찬, 홍은혜, 황삼노, 고현정, Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice , PLoS ONE , pp.1 -13 (May, 2016) [논문] Wan-Ni Yu, Wang Qi, 전상민, Xinyu Chen, Grace Guzman, Morris J. Birnbaum, Xiao-Ding Peng, Nissim Hay, Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms , CANCER CELL , Vol.29 , No.4 , pp.523 -535 (Apr, 2016) [논문] Nissim Hay, 전상민, The double-edged sword of AMPK signaling in cancer and its therapeutic implications , ARCHIVES OF PHARMACAL RESEARCH , Vol.38 , No.3 , pp.346 -357 (Mar, 2015) [논문] 전상민, Nissim Hay, The dark face of AMPK as an essential tumor promoter , CELLULAR LOGISTICS , Vol.2 , No.4 , pp.197 -202 (Oct, 2012) [논문] 전상민, Naveedip Chandel, Nissim Hay, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , NATURE , Vol.485 , pp.661 -665 (May, 2012) [논문] Chen ML, Xu PZ, 전상민, Peng XD, Nissim Hay, The effect of Akt2 deletion on tumor development in Pten+/- mice. , ONCOGENE , Vol.31 , No.4 , pp.518 -526 (Jan, 2012) [논문] Chen CC, 전상민, Bhaskar PT, Nogueira V, Park Y, Sundararajan D, Tonic I, Nissim Hay, FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor , DEVELOPMENTAL CELL , Vol.18 , No.4 , pp.592 -604 (Apr, 2010) [논문] Bhaskar PT, Nogueira V, 전상민, Park Y, Patra KC, Robey RB, Nissim Hay, mTORC1 Hyperactivity Inhibits Serum Deprivation-Induced Apoptosis via Increased Hexokinase II and GLUT1 Expression, Sustained Mcl-1 Expression, and Glycogen Synthase Kinase 3β Inhibition , MOLECULAR AND CELLULAR BIOLOGY , Vol.29 , No.18 , pp.5136 -5147 (Sep, 2009) [논문] Chen WS, 전상민, Bass J, Chen ML, Coleman K, Haschek WM, Luo Y, Peng XD, Philipson LH, Wang Y, Xu PZ, Nissim Hay, Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice , MOLECULAR AND CELLULAR BIOLOGY , Vol.29 , No.11 , pp.3151 -3162 (Jun, 2009) [논문] 전상민, 김은희, 배창대, 성연선, 최봉근, 홍경욱, 박주배, A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts , BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , Vol.348 , No.1 , pp.222 -228 (Sep, 2006) [논문] 배창대, 전상민, 김영일, 박기호, 서유신, 성연선, 안경환, 양한관, 최종선, 박주배, Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas , JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , Vol.129 , No.11 , pp.621 -630 (Nov, 2003) 국제학술발표 [학술회의] 전상민, Targeting Cancer Metabolism from a Perspective of Evolutionary Toxicology , 2021 대한약학회 추계국제학술대회 (Dec, 2021) [학술회의] 전상민, NRF2 and Cancer: a paradigm shift from an outside-in perspective , 대한약학회 추계 국제학술대회 (Oct, 2020) [학술회의] 최은지, 전상민, 박소현, Regulation of AMPK and NRF2 during metabolic stress in cancer , Forum 2019: Pharmaceutical Health Science and Environmental Toxicology (Aug, 2019) [학술회의] 최은지, 전상민, 김수열, Developing NRF2 inhibitors for cancer therapy: Clobetasol propionate and beyond , Phase 1: Where Science Becomes Medicine (Jul, 2019) [학술회의] 박건석, 전상민, 최은지, LKB1 Regulates Vitamin D Signaling in Cancer , 대한약학회 봄 정기학술대회 (Apr, 2019) [학술회의] 최은지, 전상민, 박소현, Crosstalk between AMPK and NRF2 Signaling Pathways during metabolic stress in Cancer , 대한약학회 봄 정기학술대회 (Apr, 2019) [학술회의] 전상민, 최은지, 박소현, CROSSTALK BETWEEN AMPK AND NRF2 DURING METABOLIC STRESS IN CANCER , Nature Conference on Cellular Metabolism (Apr, 2019) [학술회의] 노유진, 신수영, 전상민, Metastasis-promoting and -suppressing potentials of glucose-lowering treatment: a nationwide propensity score matched cohort study , 2018 ACCP Global Conference on Clinical Pharmacy (Oct, 2018) [학술회의] 박소현, 전상민, 최은지, The role of LKB1 and AMPK in vitamin D signaling , 2018 Fall international convention of the pharmaceutical society of Korea (Oct, 2018) [학술회의] 최은지, 전상민, 박소현, 김수열, AMPK and NRF2 cooperate to promote antioxidant defense and tumor cell survival during metabolic stress , 2018 Fall international convention of the pharmaceutical society of Korea (Oct, 2018) [학술회의] 노유진, 신수영, 전상민, Metastatic risk post primary cancer in type 2 diabetes patients with incident malignancy: effect of glucose-lowering treatment , 2018 Fall International Convention of The Pharmaceutical Soecity of Korea (Oct, 2018) [학술회의] 전상민, AMPK regulates KEAP1-NRF2 pathway during metabolic stress to promote antioxidant defense in cancer. , AMPK From Mechanisms to New Therapies (Oct, 2018) [학술회의] 전상민, Drug repositioning approach to identify NRF2 inhibitors for cancer therapy: Clobetasol propionate and beyond , Forum 2018 Pharmaceutical Health Science - Environmental Toxicology (Sep, 2018) [학술회의] 최은지, 전상민, 박소현, NRF2 promotes anchorage-independent growth of LKB1-deficient cancer cells by redirecting NADPH metabolism , 2018 Fall international convention of the pharmaceutical society of Korea (Apr, 2018) [학술회의] 정병진, 최은지, 전상민, 김수열, 이선형, Cancer therapeutic strategy targeting NRF2 by clobetasol propionate and beyond , Keystone Symposia - Tumor Metabolism (Jan, 2018) [학술회의] 신은애, 전상민, Novel connection between tumor suppressor LKB1 and vitamin D signaling , 2017 Fall International Convention of The Pharmaceutical Society of Korea (Oct, 2017) [학술회의] 전상민, Accelerating precision cancer medicine by integrating cancer genomics with drug repositioning , 대한약학회 춘계국제학술대회 (Apr, 2017) [학술회의] 정병진, 최은지, 이선형, 전상민, 신은애, 유환식, 김수열, A clinical drug library screen identifies clobetasol propionate as a potent NRF2 inhibitor and a promising repurposed therapeutic agent for lung cancers with high NRF2 activity , 대한약학회 70주년 국제학술대회 (Oct, 2016) [학술회의] 전상민, Understanding metabolic adaptations for cancer therapy , 2016 Cancer Metabolism: Light in the Darkness (Sep, 2016) [학술회의] 최은지, 전상민, Georgia Hatzivassiliou, Dual activation of AMPK and NRF2 during metabolic stress defines co-operating antioxidant defense mechanisms in cancer , Keystone Symposia - Frontiers in Cancer Metabolism (Feb, 2016) [학술회의] 전상민, Integrative Approaches to Develop Novel Therapeutic Strategies by Exploring the LKB1-AMPK Paradox in Lung Cancer , 2015 Bio Korea (Apr, 2015) [학술회의] 전상민, Therapeutic Implications and Business Development by Regulation of LKB1-AMPK Pathway in Cancer , 제 1차 한중 암대사 워크숍 , pp.19 -20 (Dec, 2014) [학술회의] 전상민, Metabolism and Cancer: Old Friends are the Best Friends , 2014 Spring International Convention of The Parmaceutical Society of korea (Apr, 2014) 국내학술발표 [학술회의] 전상민, eTOX-Based Cancer Research & Drug Discovery Platform , 2022 제1회 소화기질환 중개연구 심포지엄 (Oct, 2022) [학술회의] 전상민, Cancer research from a perspective of evolutionary toxicology , 2021 한국응용약물학회 추계학술대회 (Oct, 2021) [학술회의] 전상민, NRF2 and cancer: An emerging paradigm from an outside-in perspective , 2020 IRIDD Symposium on Metabolism and Metabolic Diseases (Dec, 2020) [학술회의] 노유진, 신수영, 전상민, Impact of NRF2 modulating antidiabetics on the risk of metastatic progression of underlying malignancy in diabetic cancer patients , 뉴노멀시대 임상약학 교육-연구-실무의 성과와 도전 (Nov, 2020) [학술회의] 전상민, GR-NRF2 axis as a novel therapeutic target of cancer metabolism , 제8회 KSBMB DDC 제주 워크숍 (Jul, 2020) [학술회의] 전상민, Understanding cancer metabolism from an outside-in perspective , 2020 대한암학회 춘계 학술대회 (Jun, 2020) [학술회의] 전상민, Cancer metabolism from an outside-in perspective , 제11회 동계학술대회 2020 KSBMB (Jan, 2020) [학술회의] 전상민, Targeting redox metabolism for cancer therapy: From the bench to the bedside , 제7회 신약개발컨소시엄 제주 워크숍 (Jul, 2019) [학술회의] 전상민, Cancer metabolism from an evolutionary perspective , Cancer Metabolism Workshop in Korea (Mar, 2019) [학술회의] 전상민, The origin of cancer from a metabolic perspective , 2018 Cancer Metabolism Workshop (Feb, 2018) [학술회의] 전상민, Targeting NRF2 for cancer therapy by drug repositioning approach , 생명약학연구회-한국약제학회 동계 심포지엄 (Feb, 2018) [학술회의] 전상민, Cancer Metabolism: Time to Rethink Warburg Effect and Cancer , 한국수지상세포학회 (Dec, 2017) [학술회의] 전상민, Drug repositioning approach to identify NRF2 inhibitors for cancer therapy , 한국프리라디칼학회 (Nov, 2017) [학술회의] 전상민, Integration of Signaling & Metabolism for Cancer Therapy , 한국생약학회 (Nov, 2017) [학술회의] 최은지, 전상민, 정병진, 김수열, 이선형, Targeting NRF2 for cancer therapy , 추계약학회 (Oct, 2017) [학술회의] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 , 대한약학회 (Oct, 2017) [학술회의] 전상민, Bridging the layers: integration of cancer genomics, signaling and metabolism network for cancer therapy , KSBMB DDC 제주 워크샵 (Jul, 2017) [학술회의] 전상민, New insights into the mechanisms of metabolic adaptation in cancer , (사)대한약학회 신약개발네트워크분과 창립기념 심포지움 (Apr, 2017) [학술회의] 정병진, 최은지, 이선형, 전상민, 김수열, Clobetasol propionate, a synthetic glucocorticoid, is a novel GSK3-dependent NRF2 inhibitor displaying promising therapeutic efficacy in KEAP1-mutant lung cancers , 하이원 신약개발 심포지엄 (Jan, 2017) [학술회의] 유환식, 최은지, 전상민, Georgia Hatzivassiliou, AMPK and NRF2 cooperate to promote tumor cell survival during metabolic stress , 하이원 신약개발 심포지엄 (Jan, 2017) [학술회의] 최은지, 전상민, Georgia Hatzivassiliou, Co-occurring mutations in LKB1 and KEAP1 in lung cancer synergize tumor growth , 하이원 신약개발 심포지엄 (Jan, 2017) [학술회의] 전상민, Exploiting Metabolic Adaptations for Cancer Therapy , 한국유방암학회 중개연구회 심포지엄 (Nov, 2016) [학술회의] 전상민, NRF2 조절을 통한 폐암 치료 신약개발 , 신약개발분과회 추계 워크숍 (Oct, 2016) [학술회의] 전상민, Dissecting the Role of AMPK in Cancer , 2016 대한신경종양학회 추계학술대회 (Sep, 2016) [학술회의] 전상민, The LKB1-AMPK and KEAP1-NRF2 pathways synergize antioxidant defense during metabolic stress in cancer , 2016 cMIG 춘계 워크숍 (Mar, 2016) [학술회의] 정병진, 전상민, 최은지, A clinical drug library screen identifies glucocorticoids as novel NRF2 inhibitors and promising repurposed therapeutics for lung cancers with high NRF2 activity. , 하이원신약개발심포지아 (Jan, 2016) [학술회의] 최은지, 전상민, Georgia Hatzivassiliou, High frequency of co-occurring mutations in LKB1 and KEAP1 in lung cancer confers combinatorial oncogenic driver pathway allowing concurrent activation of both mTORC1-mediated growth and NRF2-mediated antioxidant defense , 하이원신약개발심포지아 (Jan, 2016) [학술회의] 전상민, Dual activation of AMPK and NRF2 during metabolic stress is a critical fail-safe mechanism for metabolic adaptation in cancer , 제5차 암대사 워크숍 (Nov, 2015) [학술회의] 전상민, Novel therapeutic opportunities behind the LKB1-AMPK paradox in lung cancer , The 2nd KSBMB DDC JEJU WORKSHOP (Jul, 2015) [학술회의] 전상민, Business development by regulation of metabolic pathway in cancer and challenges for clinical application , 2015년 한국임상암학회 제 13차 정기 심포지움 및 총회 (May, 2015) [학술회의] 전상민, Understanding the LKB1-AMPK pathway in cancer for novel therapeutic interventions , 2015년 생명 약학 연구회 동계 심포지엄 (Feb, 2015) [학술회의] 전상민, Developing novel anti-cancer strategies integrating cancer genomics, signaling and metabolism network , 2014 Lee Gil Ya Cancer and Diabetes Institute Symposium , pp.31 -33 (Nov, 2014) [학술회의] 전상민, Exploring the LKB1-AMPK paradox and Its Implications for Cancer Therapy , 제 38회 세포생물학회 하계 학술대회 , pp.31 -31 (Jul, 2014) [학술회의] 전상민, Exploring the LKB1 Paradox in Cancer: A Tumor Suppressor with a Key Role in Tumor Stress Adaptation and Its Therapeutic Implications , 동아 제 1차 항암 미니 심포지엄 (Apr, 2014) [학술회의] 전상민, Exploring the LKB1 paradox: a tumor suppressor with a key role in tumor stress adaptation , 제5회 생화학분자생물학회 동계학술대회 (Jan, 2014) [학술회의] 전상민, Georgia Hatzivassiliou, Anneleen Daemen, David Stokoe, Leisa Johnson, Exploring the LKB1-AMPK paradox: A tumor suppressor pathway with a key role in tumor stress adaptation , 제1회 아주대학교 의약학 공동 심포지움 (Sep, 2013) 저서 및 번역 [저서] 전상민, 기성환, 김민선, 김성연, 김은희, 김희진, 박광식, 이상규, 이윤희, 임경민, 정광원, 정영석, 정재훈, 정주희, 창동신, 천경수, 한선영, Casarett & Doull's Essentials of Toxicology, 3rd edition (Sep, 2018) [저서] 전상민, 기성환, 김규봉, 김대경, 김상겸, 김성연, 김영미, 김영철, 김은희, 김형식, 김환묵, 노윤석, 박광식, 박애경, 박영자, 배옥남, 배지현, 신윤용, 신태용, 양미희, 오승현, 유환수, 윤여표, 이무열, 이병훈, 이상규, 이윤희, 이은영, 이주영, 이효종, 임경민, 정규혁, 정세영, 정영석, 정주희, 정진호, 정태천, 정혜광, 창동신, 천경수, 최성숙, 허문영, 예방약학 8판 (Mar, 2017) [저서] 전상민, 임상독성학 , pp.221~227 (Mar, 2015)
특허 및 기타	[특허] 전상민, 신규 화합물 및 이의 용도 (등록) (10-2652185) (Mar, 2024) [특허] 전상민, 신규 화합물 및 이의 용도 (출원) (PCT/KR2024/095093) (Feb, 2024) [특허] 전상민, 인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물 (출원) (PCT/KR2024/095095) (Feb, 2024) [특허] 전상민, 신규 화합물 및 이의 항암 용도 (출원) (PCT/KR2024/095094) (Feb, 2024) [특허] 전상민, 신규 화합물 및 이의 용도 (등록) (10-2604396) (Nov, 2023) [특허] 전상민, 신규 화합물 및 이의 용도 (등록) (10-2571432) (Aug, 2023) [특허] 전상민, 신규 화합물 및 이의 용도 (등록) (10-2544591) (Jun, 2023) [특허] 전상민, 벤젠 유도체 화합물을 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 (출원) ( 10-2023-0043922) (Apr, 2023) [특허] 전상민, 다이아진 유도체 화합물을 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 (출원) (10-2023-0043927) (Apr, 2023) [특허] 전상민, 나프탈렌 유도체 화합물을 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 (출원) ( 10-2023-0043929) (Apr, 2023) [특허] 전상민, 세포 대사 억제용 화합물을 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 (출원) (10-2023-0043932) (Apr, 2023) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 염증의 예방 또는 치료용 약학적 조성물 (출원) (10-2023-0029731) (Mar, 2023) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 암의 예방 또는 치료용 약학적 조성물 (출원) (10-2023-0027548) (Mar, 2023) [특허] 전상민, 인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물 (출원) (10-2023-0016501) (Feb, 2023) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 (등록) (11,260,062) (R0420US) (Mar, 2022) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 (등록) (ZL201680064090.8) (R0420CN) (May, 2021) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-2000425) (Jul, 2019) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-2000424) (Jul, 2019) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-1978629) (May, 2019) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-1892908) (Aug, 2018) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 (출원) (PCT/KR2016/012534) (Nov, 2016) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (출원) (10-2015-0153089) (Nov, 2015)

빠른 이동 메뉴